Dr. Thomas Lee Mcgrew, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6803 Mayfield Rd, Ste 305, Mayfield Heights, OH 44124 Phone: 440-312-9000 Fax: 440-312-9001 |
Katherine A Singh, MD Obstetrics & Gynecology - Maternal & Fetal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6770 Mayfield Rd, Suite 336, Mayfield Heights, OH 44124 Phone: 440-312-7702 Fax: 440-312-7733 |
Amanda Kalan, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6770 Mayfield Rd, Suite 336, Mayfield Heights, OH 44124 Phone: 440-312-2229 Fax: 440-312-7725 |
Jeff B Chapa, MD Obstetrics & Gynecology - Maternal & Fetal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6770 Mayfield Rd, Suite 336, Mayfield Heights, OH 44124 Phone: 440-312-8888 Fax: 440-312-7725 |
News Archive
Catheter Connections, a start-up company co-founded by nurses seeking to reduce deadly hospital-acquired bloodstream infections, announced today the issuance of U.S. Patent Number 8,419,713, titled "Carrier Assembly With Caps for Medical Connectors."
Women don't need to run marathons or do intense aerobics to reduce their stroke risk. Moderate-intensity exercise - such as brisk walking or playing tennis - may do the trick, according to research presented at the American Stroke Association's International Stroke Conference 2014.
The U.S. Food and Drug Administration today announced steps to help reduce the risk of exposure to improperly reprocessed devices that can lead to the transmission of disease.
The ProScanĀ® III system from Prior Scientific provides a flexible, high performance control system for Prior microscope accessories including motorised stages, focusing devices, filter wheels, illumination devices, shutters as well as robotic sample loaders for well plates and slides.
Exelixis, Inc. today announced a restructuring as a consequence of its continued strategy to focus resources on the development of its key late-stage compounds. As its first priority, the company will aggressively advance XL184, XL147 and XL765, each of which is the subject of a large clinical development program.
› Verified 3 days ago